Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

921 recalls · Class II, newest first

Class II · Moderate risk

Chantix (varenicline)

CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDAs acceptable interim acceptable intake limit

Ongoing Nitrosamine impurity Pfizer Inc. NDC 0069-0469-56 D-0701-2021
Class II · Moderate risk

Chantix (varenicline)

CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDAs acceptable interim acceptable intake limit

Ongoing Nitrosamine impurity Pfizer Inc. NDC 0069-0471-03 D-0700-2021
Class II · Moderate risk

Chantix (varenicline)

CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit

Ongoing Nitrosamine impurity Pfizer Inc. NDC 0069-0468-56 D-0699-2021
Class II · Moderate risk

Xolair (omalizumab)

Failed Stability Specifications: Out of Specification results of Polysorbate 20 (PS20) content were detected at the 12 month testing time point.

Terminated Stability / shelf life Genentech Inc D-0650-2021
Class II · Moderate risk

DermOtic Oil

Presence of Foreign Substance: Potential for broken glass within the glass pipette of the dropper.

Terminated Particulate / foreign matter Hill Dermaceuticals, Inc. NDC 68791-103-20 D-0637-2021
Class II · Moderate risk

Daytrana (methylphenidate transdermal system)

Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.

Ongoing Packaging defect Noven Pharmaceuticals Inc NDC 68968-5553-1 D-0394-2021
Class II · Moderate risk

Daytrana (methylphenidate transdermal system)

Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.

Ongoing Packaging defect Noven Pharmaceuticals Inc NDC 68968-5552-1 D-0393-2021
Class II · Moderate risk

MEDICALLY MINDED Hand Sanitizer Gel

CGMP Deviations: lots and products of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.

Ongoing Chemical / undeclared Global Sanitizers LLC D-0783-2021
Class II · Moderate risk

MEDICALLY MINDED Hand Sanitizer Gel

CGMP Deviations: lots and products of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.

Ongoing Chemical / undeclared Global Sanitizers LLC D-0782-2021
Class II · Moderate risk

MEDICALLY MINDED Hand Sanitizer Gel

CGMP Deviations: lots and products of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.

Ongoing Chemical / undeclared Global Sanitizers LLC D-0779-2021
Class II · Moderate risk

Advance Hand Sanitizer

CGMP Deviations: Other lots and products of hand sanitizer recalled because they were manufactured under the same conditions as the product lots found to contain methanol.

Terminated Chemical / undeclared Dibar Nutricional S De Rl De Cv D-0647-2021
Class II · Moderate risk

ProtectoRx

CGMP Deviations: Other lots and products of hand sanitizer recalled because they were manufactured under the same conditions as the product lots found to contain methanol.

Terminated Chemical / undeclared Dibar Nutricional S De Rl De Cv NDC 75408-002-01 D-0646-2021
Class II · Moderate risk

DiBAR LABS Hand Sanitizer

CGMP Deviations: Other lots and products of hand sanitizer recalled because they were manufactured under the same conditions as the product lots found to contain methanol.

Terminated Chemical / undeclared Dibar Nutricional S De Rl De Cv NDC 73009-001-16 D-0645-2021
Class II · Moderate risk

Imperia Elita Vitaccino Coffee

Marketed without an approved NDA/ANDA: FDA analysis determined presence of the pharmaceutical ingredients Sibutramine and Fluoxetine

Ongoing Chemical / undeclared Dash Xclusive D-0628-2021

Recalls by year